Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension

Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy

(2009) Giovanni Corrao et al.   JOURNAL OF HYPERTENSION

Impact of New-Onset Diabetes Mellitus on Development of Atrial Fibrillation and Heart Failure in High-Risk Hypertension (from the VALUE Trial)

(2008) Tonje Amb Aksnes et al.   AMERICAN JOURNAL OF CARDIOLOGY

Beyond the Randomized Clinical Trial

(2008) Brahmajee K. Nallamothu et al.   CIRCULATION

Prevalence and incidence of Type 2 diabetes and its complications 1996-2003-estimates from a Swedish population-based study

(2008) A. Ringborg et al.   DIABETIC MEDICINE

Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data

(2008) A. Ringborg et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Global burden of blood-pressure-related disease, 2001

(2008) Carlene MM Lawes et al.   LANCET

Sartan–AT1 receptor interactions: In vitro evidence for insurmountable antagonism and inverse agonism

(2008) I. Van Liefde et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE